Drug Shortage Report for APO-DILTIAZ CD

Last updated on 2021-08-31 History
Report ID 142674
Drug Identification Number 02229526
Brand name APO-DILTIAZ CD
Common or Proper name DILTIAZ CD
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 300MG
Dosage form(s) CAPSULE (CONTROLLED-DELIVERY)
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-07-12
Estimated end date 2021-09-24
Actual end date 2021-08-27
Shortage status Resolved
Updated date 2021-08-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-08-31 French Compare
v3 2021-08-31 English Compare
v2 2021-07-16 French Compare
v1 2021-07-16 English Compare

Showing 1 to 4 of 4